Eli Lilly and Company to Settle Dispute Over Drug Copies
Eli Lilly is poised to make a cash payment to settle a long-running dispute with Indian generic drugmakers over low-cost copies of the US company’s medicines that were impounded within the European Union.
The US-based pharmaceuticals company was one of several innovative drug companies that benefited from a decision by the Dutch authorities to block shipments of low-cost rival generic versions of their products in 2008-09.